International consensus statement on allergy and rhinology: rhinosinusitis

RR Orlandi, TT Kingdom, PH Hwang… - International forum of …, 2016 - Wiley Online Library
Contributing Authors Isam Alobid, MD, PhD1, Nithin D. Adappa, MD2, Henry P. Barham,
MD3, Thiago Bezerra, MD4, Nadieska Caballero, MD5, Eugene G. Chang, MD6, Gaurav …

[HTML][HTML] Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

X Bossuyt, JW Cohen Tervaert, Y Arimura… - Nature Reviews …, 2017 - nature.com
Anti-neutrophil cytoplasmic antibodies (ANCAs) are valuable laboratory markers used for
the diagnosis of well-defined types of small-vessel vasculitis, including granulomatosis with …

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis

JC Robson, PC Grayson, C Ponte… - Arthritis & …, 2022 - Wiley Online Library
Objective To develop and validate revised classification criteria for granulomatosis with
polyangiitis (GPA). Methods Patients with vasculitis or comparator diseases were recruited …

[HTML][HTML] Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

AC Medeiros-Ribeiro, NE Aikawa, CGS Saad… - Nature medicine, 2021 - nature.com
CoronaVac, an inactivated SARS-CoV-2 vaccine, has been approved for emergency use in
several countries. However, its immunogenicity in immunocompromised individuals has not …

[HTML][HTML] External review and validation of the Swedish national inpatient register

JF Ludvigsson, E Andersson, A Ekbom, M Feychting… - BMC public health, 2011 - Springer
Abstract Background The Swedish National Inpatient Register (IPR), also called the Hospital
Discharge Register, is a principal source of data for numerous research projects. The IPR is …

[HTML][HTML] Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

RB Jones, JW Cohen Tervaert, T Hauser… - … England Journal of …, 2010 - Mass Medical Soc
Background Cyclophosphamide induction regimens for antineutrophil cytoplasmic antibody
(ANCA)–associated vasculitis are effective in 70 to 90% of patients, but they are associated …

EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis …

S Ozen, A Pistorio, SM Iusan, A Bakkaloglu… - Annals of the …, 2010 - ard.bmj.com
Objectives To validate the previously proposed classification criteria for Henoch–Schönlein
purpura (HSP), childhood polyarteritis nodosa (c-PAN), c-Wegener granulomatosis (c-WG) …

Highlights on US FDA-approved fluorinated drugs over the past five years (2018–2022)

S Ali, J Zhou - European journal of medicinal chemistry, 2023 - Elsevier
The objective of this review is to provide an update on the fluorine-containing drugs
approved by US Food and Drug Administration in the span of past five years (2018–2022) …

The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort

L Guillevin, C Pagnoux, R Seror, A Mahr, L Mouthon… - Medicine, 2011 - journals.lww.com
Abstract The 1996 Five-Factor Score (FFS) for systemic necrotizing vasculitides (polyarteritis
nodosa [PAN], microscopic polyangiitis [MPA], and Churg-Strauss syndrome [CSS]) is used …

ANCA-associated vasculitis—clinical utility of using ANCA specificity to classify patients

D Cornec, ECL Gall, FC Fervenza… - Nature Reviews …, 2016 - nature.com
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a
heterogeneous group of rare syndromes characterized by necrotizing inflammation of small …